These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 28838179)

  • 1. Implementing the Synchronized Global Switch from Trivalent to Bivalent Oral Polio Vaccines-Lessons Learned From the Global Perspective.
    Ramirez Gonzalez A; Farrell M; Menning L; Garon J; Everts H; Hampton LM; Dolan SB; Shendale S; Wanyoike S; Veira CL; Châtellier GMD; Kurji F; Rubin J; Boualam L; Chang Blanc D; Patel M
    J Infect Dis; 2017 Jul; 216(suppl_1):S183-S192. PubMed ID: 28838179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Communications, Immunization, and Polio Vaccines: Lessons From a Global Perspective on Generating Political Will, Informing Decision-Making and Planning, and Engaging Local Support.
    Menning L; Garg G; Pokharel D; Thrush E; Farrell M; Kodio FK; Veira CL; Wanyoike S; Malik S; Patel M; Rosenbauer O
    J Infect Dis; 2017 Jul; 216(suppl_1):S24-S32. PubMed ID: 28838189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Introduction of Inactivated Poliovirus Vaccine and Trivalent Oral Polio Vaccine/Bivalent Oral Polio Vaccine Switch in the African Region.
    Tevi-Benissan C; Okeibunor J; du Châtellier GM; Assefa A; Biey JN; Cheikh D; Eshetu M; Anya BP; Dao H; Nasir Y; Akanmori BD; Mihigo R
    J Infect Dis; 2017 Jul; 216(suppl_1):S66-S75. PubMed ID: 28838178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of potential non-synchronous cessation.
    Duintjer Tebbens RJ; Hampton LM; Thompson KM
    BMC Infect Dis; 2016 May; 16():231. PubMed ID: 27230071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience With Inactivated Polio Vaccine Introduction and the "Switch" From Trivalent to Bivalent Oral Polio Vaccine in the World Health Organization's Western Pacific Region.
    Gurung S; Harris JB; Eltayeb AO; Hampton LM; Diorditsa S; Avagyan T; Schluter WW
    J Infect Dis; 2017 Jul; 216(suppl_1):S101-S108. PubMed ID: 28838170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cessation of Trivalent Oral Poliovirus Vaccine and Introduction of Inactivated Poliovirus Vaccine - Worldwide, 2016.
    Hampton LM; Farrell M; Ramirez-Gonzalez A; Menning L; Shendale S; Lewis I; Rubin J; Garon J; Harris J; Hyde T; Wassilak S; Patel M; Nandy R; Chang-Blanc D;
    MMWR Morb Mortal Wkly Rep; 2016 Sep; 65(35):934-8. PubMed ID: 27606675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polio endgame: the global switch from tOPV to bOPV.
    Garon J; Seib K; Orenstein WA; Ramirez Gonzalez A; Chang Blanc D; Zaffran M; Patel M
    Expert Rev Vaccines; 2016 Jun; 15(6):693-708. PubMed ID: 26751187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introduction of Inactivated Poliovirus Vaccine and Switch from Trivalent to Bivalent Oral Poliovirus Vaccine - Worldwide, 2013-2016.
    Immunization Systems Management Group of the Global Polio Eradication Initiative
    MMWR Morb Mortal Wkly Rep; 2015 Jul; 64(25):699-702. PubMed ID: 26135591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use.
    Duintjer Tebbens RJ; Hampton LM; Thompson KM
    BMC Infect Dis; 2016 Jun; 16():237. PubMed ID: 27246198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. India's Preparedness for Introduction of IPV and Switch from tOPV to bOPV.
    Haldar P; Agrawal P
    Indian Pediatr; 2016 Aug; 53 Suppl 1():S44-S49. PubMed ID: 27771639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring and Validation of the Global Replacement of tOPV with bOPV, April-May 2016.
    Farrell M; Hampton LM; Shendale S; Menning L; Gonzalez AR; Garon J; Dolan SB; du Châtellier GM; Wanyoike S; Chang Blanc D; Patel MM
    J Infect Dis; 2017 Jul; 216(suppl_1):S193-S201. PubMed ID: 28838162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposing of Excess Vaccines After the Withdrawal of Oral Polio Vaccine.
    Wanyoike S; Ramirez Gonzalez A; Dolan SB; Garon J; Veira CL; Hampton LM; Chang Blanc D; Patel MM
    J Infect Dis; 2017 Jul; 216(suppl_1):S202-S208. PubMed ID: 28838168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eradicating polio: how the world's pediatricians can help stop this crippling illness forever.
    Orenstein WA;
    Pediatrics; 2015 Jan; 135(1):196-202. PubMed ID: 25548328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The global switch from trivalent oral polio vaccine (tOPV) to bivalent oral polio vaccine (bOPV): facts, experiences and lessons learned from the south-south zone; Nigeria, April 2016.
    Bassey BE; Braka F; Vaz RG; Komakech W; Maleghemi ST; Koko R; Igbu T; Ireye F; Agwai S; Akpan GU; Tegegne SG; Mohammed AG; Okocha-Ejeko A
    BMC Infect Dis; 2018 Jan; 18(1):57. PubMed ID: 29374467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Financial Support to Eligible Countries for the Switch From Trivalent to Bivalent Oral Polio Vaccine-Lessons Learned.
    Shendale S; Farrell M; Hampton LM; Harris JB; Kachra T; Kurji F; Patel M; Ramirez Gonzalez A; Zipursky S
    J Infect Dis; 2017 Jul; 216(suppl_1):S57-S65. PubMed ID: 28838171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematization of the Introduction of IPV and Switch from tOPV to bOPV in the Americas.
    Pedreira C; Thrush E; Jauregui B
    J Infect Dis; 2017 Jul; 216(suppl_1):S76-S85. PubMed ID: 28838161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidance for Assessment of Poliovirus Vaccination Status and Vaccination of Children Who Have Received Poliovirus Vaccine Outside the United States.
    Marin M; Patel M; Oberste S; Pallansch MA
    MMWR Morb Mortal Wkly Rep; 2017 Jan; 66(1):23-25. PubMed ID: 28081056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Switch From Trivalent to Bivalent Oral Poliovirus Vaccine in the South-East Asia Region.
    Bahl S; Hasman A; Eltayeb AO; James Noble D; Thapa A
    J Infect Dis; 2017 Jul; 216(suppl_1):S94-S100. PubMed ID: 28838177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The differential impact of oral poliovirus vaccine formulation choices on serotype-specific population immunity to poliovirus transmission.
    Thompson KM; Duintjer Tebbens RJ
    BMC Infect Dis; 2015 Sep; 15():376. PubMed ID: 26382234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introduction of Inactivated Polio Vaccine, Withdrawal of Type 2 Oral Polio Vaccine, and Routine Immunization Strengthening in the Eastern Mediterranean Region.
    Fahmy K; Hampton LM; Langar H; Patel M; Mir T; Soloman C; Hasman A; Yusuf N; Teleb N
    J Infect Dis; 2017 Jul; 216(suppl_1):S86-S93. PubMed ID: 28838199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.